Strata Skin Sciences Q2 Sales $8.40M Beat $7.42M Estimate
Portfolio Pulse from Benzinga Newsdesk
Strata Skin Sciences (NASDAQ:SSKN) reported Q2 sales of $8.40 million, surpassing the analyst consensus estimate of $7.42 million by 13.15%. This marks a 1.82% increase over the same period last year.
August 14, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Strata Skin Sciences reported Q2 sales of $8.40 million, beating the analyst consensus estimate of $7.42 million by 13.15%. This is a positive indicator for the company's financial health and could lead to a short-term increase in stock price.
The company's Q2 sales exceeded expectations by a significant margin, which is likely to be viewed positively by investors. This could result in a short-term increase in the stock price as the market reacts to the better-than-expected performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100